Upregulation of bone morphogenetic protein 1 is associated with poor prognosis of late-stage gastric Cancer patients

BACKGROUND: Gastric cancer is the eighth most common cancer in Taiwan, with a 40% 5-year survival rate. Approximately 40% of patients are refractory to chemotherapy. Currently, the anti-HER2 therapy is the only clinically employed targeted therapy. However, only 7% patients in Taiwan are HER2-positi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsieh, Yung-Yu, Tung, Shui-Yi, Pan, Hung-Yu, Yen, Chih-Wei, Xu, Huang-Wei, Deng, Yi-Fang, Lin, Ying-Jhen, Hsu, Wan-Ting, Wu, Cheng-Shyong, Li, Chin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5930761/
https://www.ncbi.nlm.nih.gov/pubmed/29720137
http://dx.doi.org/10.1186/s12885-018-4383-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5930761/
https://www.ncbi.nlm.nih.gov/pubmed/29720137
http://dx.doi.org/10.1186/s12885-018-4383-9

Ejemplares similares